Latest International Expansion News

NeuRizer Ltd has advanced its NeuRizer Urea Project with key environmental approvals and construction plans, while raising $350,000 through private placements. However, the company faces a trading suspension as it works to resolve audit and compliance issues with the ASX.

Sierra Nevada Gold has established a wholly owned Saudi subsidiary, Arabian American Minerals LLC, to spearhead exploration at the As Safra copper-gold project, aligning with Saudi Arabia’s Vision 2030 and preparing for imminent drilling.

InFocus Group’s Prodigy9 has received its initial payment for a major Thai Government social security infrastructure project, signalling progress and potential expansion.

Firebrick Pharma has secured its first regulatory approval for Nasodine Nasal Spray in Indonesia, paving the way for entry into Southeast Asia’s largest market. This milestone marks a significant step in the company’s international expansion strategy.

AML3D has landed a AU$2.61 million contract to produce critical submarine components for the US Navy using its advanced 3D metal printing technology, marking a significant step in its US defence expansion.

Latrobe Magnesium Limited has successfully produced around 20 tonnes of high-grade Magnesium Oxide from its Hazelwood North Demonstration Plant, paving the way for magnesium metal production later this year.

Memphasys Limited confirms uninterrupted operations across the Middle East and North Africa, securing new orders and advancing regulatory approvals despite ongoing regional tensions.

Ovanti Limited is reshaping its future with a strategic shift from its BNPL roots to a global financial Super App, exiting legacy US operations to focus on innovation and international expansion.

Bio-Gene has signed a term sheet with Sumitomo Corporation and Nakashima Trading to introduce its 100% natural insecticide Qcide® to Japan’s $1 billion household pest market, aiming for a late 2026 launch.

Cobram Estate Olives has secured US Department of Justice approval for its acquisition of California Olive Ranch, paving the way for completion by late March 2026.

RLF AgTech has completed its restructuring phase and is now shifting gears towards aggressive commercial execution under new CEO Stuart Upton. The company outlined its growth strategy and financial results in a recent investor webinar, signalling a clear path to profitability.

Rhythm Biosciences has inked a pivotal distribution agreement with UK-based Digistain Limited to introduce its geneType™ genetic test portfolio in Southeast Asia, starting with the Philippines. This marks Rhythm’s first commercial foothold in the region, setting the stage for broader expansion.